Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTK | P33981 | 6/20 | 0.34 |
| ▸ | PTK6 | Q13882 | 2/20 | 0.34 |
| ▸ | CDK2 | P24941 | 2/20 | 0.33 |
| ▸ | CDK1 | P06493 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 4/20 | 0.32 |
| ▸ | MAPKAPK5 | Q8IW41 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22123385 | 0.96 | TTK (0.33) | TTKPTK6CDK2CDK1IDO1 | |
| SCHEMBL22123785 | 0.93 | MAPKAPK5 (0.35) | TTKPTK6CDK2CDK1IDO1 | |
| SCHEMBL22122906 | 0.93 | MAPKAPK5 (0.34) | TTKPTK6CDK2CDK1IDO1 | |
| SCHEMBL22123290 | 0.92 | MAPKAPK5 (0.34) | TTKPTK6CDK2CDK1IDO1 | |
| SCHEMBL30171532 | 0.92 | MAPKAPK5 (0.34) | TTKPTK6CDK2CDK1IDO1 | |
| SCHEMBL30183696 | 0.91 | BRD4 (0.38) | TTKPTK6IDO1MAPKAPK5BRD4 | |
| SCHEMBL22122823 | 0.91 | MAPKAPK5 (0.33) | TTKPTK6CDK2CDK1IDO1 | |
| SCHEMBL22123367 | 0.91 | BRD4 (0.38) | TTKPTK6IDO1MAPKAPK5BRD4 | |
| SCHEMBL25176067 | 0.91 | PTK6 (0.37) | TTKPTK6IDO1MAPKAPK5 | |
| SCHEMBL22123412 | 0.90 | MAPKAPK5 (0.33) | TTKPTK6CDK2CDK1MAPKAPK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3898631-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS | F. Hoffmann-La Roche AG (CH) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020126953-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-25 | — | — | WO | disclosed |